Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Study With Nexavar About Safety and Efficacy in Carcinoma Hepatocellular Therapy (HCC)

NCT00792350 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00792350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00792350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Study With Nexavar About Safety and Efficacy in Carcinoma Hepatocellular Therapy (HCC)
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
April 30, 2008
Completion date
April 30, 2014
Enrollment
791 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, hepatocellular